Article
Levelling out differences in aerobic glycolysis neutralizes the competitive advantage of…
medRxiv · 2021 · Albert Herms
Key facts
| Title | Levelling out differences in aerobic glycolysis neutralizes the competitive advantage of oncogenic PIK3CA mutant progenitors in the esophagus |
|---|---|
| First author | Albert Herms |
| Journal | medRxiv |
| Published | May 28, 2021 |
| DOI | 10.1101/2021.05.28.446104 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K190495 |
| Product codes mentioned | DDG, NDS, PCA, JCI, JJH, KIP, KIT, MVU, NJT, OOI, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1